Inhaled Nitric Oxide Study for Respiratory Failure in Newborns

NCT00005776 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

235

Enrollment

NETWORK

Sponsor class

Stopped Results showed statistically significant benefit in the experimental group

Conditions

Infant, Newborn
Hypertension, Pulmonary
Persistent Fetal Circulation Syndrome
Pneumonia, Aspiration
Respiratory Distress Syndrome, Newborn
Respiratory Insufficiency

Interventions

DRUG: Inhaled nitric oxide
DRUG: Placebo

Sponsor

NICHD Neonatal Research Network

Collaborators

[object Object]
[object Object]